医学
易普利姆玛
彭布罗利珠单抗
肿瘤科
内科学
免疫疗法
癌症
作者
Georgina V. Long,M.S. Carlino,Catriona M. McNeil,Antoni Ribas,C. Gaudy‐Marqueste,Jacob Schachter,Marta Nyakas,Damien Kee,Teresa M. Petrella,Arnold Blaustein,Michal Lotem,Ana Arance,Adil Daud,Omid Hamid,James Larkin,Jia Li,Rohit Kumar Singh,Richa Lal,Caroline Robert
标识
DOI:10.1016/j.annonc.2024.08.2330
摘要
Pembrolizumab significantly improved overall survival (OS) versus ipilimumab for unresectable advanced melanoma in KEYNOTE-006 (NCT01866319); 10-year follow-up data are presented.
科研通智能强力驱动
Strongly Powered by AbleSci AI